Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period

Kenneth Fife, Barry Katz, Edward J. Brizendine, Darron Brown

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

OBJECTIVE: Our goal was to determine the persistence of human papillomavirus infection of the cervix in a prospectively evaluated cohort of pregnant women observed from the first trimester until after delivery. STUDY DESIGN: A group of 232 women were enrolled in the first trimester of pregnancy and had cervicovaginal lavage specimens collected for detection of the deoxyribonucleic acid of human papillomavirus. They underwent sampling again in the third trimester (146 patients available) and at 4 to 12 weeks after delivery (83 patients available). Human papillomavirus deoxyribonucleic acid was detected by means of the Hybrid Capture assay. RESULTS: In the first trimester of pregnancy, 31% of the patients had positive test results for human papillomavirus deoxyribonucleic acid, whereas 35.6% had positive results in the third trimester (P = 1.0). A comparison of first-trimester test results with postpartum results (paired data available from 83 patients) showed a decline from 39.8% positivity to 26.5% (P = .04). Comparing third- trimester results with postpartum results (paired data available from 74 patients) showed a decline from 35.1% to 25.7% positivity (P = .12). When specimens positive for human papillomavirus were divided between those containing 'high cancer risk' types (9 virus types often associated with dysplasia or malignancy) and 'low cancer risk' types (5 types usually found in benign lesions), similar trends were seen, although not all comparisons were statistically significant. CONCLUSION: The increased prevalence, during pregnancy, of detectable human papillomavirus deoxyrlbonucleic acid, which was previously reported (Fife et al, Am J Obstet Gynecol 1996;174:1487-93), persists at a similar level throughout pregnancy but declines in the postpartum period. This observation is most consistent with activation of the virus by the physiologic changes of pregnancy.

Original languageEnglish (US)
Pages (from-to)1110-1114
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume180
Issue number5
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Postpartum Period
First Pregnancy Trimester
Pregnancy
DNA
Third Pregnancy Trimester
Virus Activation
Neoplasms
Papillomavirus Infections
Therapeutic Irrigation
Cervix Uteri
Pregnant Women
Viruses
Acids

Keywords

  • Cervical dysplasia
  • Detection of deoxyribonucleic acid
  • Papillomavirus
  • Pregnancy

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

@article{503aa764b7f947df96fd5251ce888849,
title = "Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period",
abstract = "OBJECTIVE: Our goal was to determine the persistence of human papillomavirus infection of the cervix in a prospectively evaluated cohort of pregnant women observed from the first trimester until after delivery. STUDY DESIGN: A group of 232 women were enrolled in the first trimester of pregnancy and had cervicovaginal lavage specimens collected for detection of the deoxyribonucleic acid of human papillomavirus. They underwent sampling again in the third trimester (146 patients available) and at 4 to 12 weeks after delivery (83 patients available). Human papillomavirus deoxyribonucleic acid was detected by means of the Hybrid Capture assay. RESULTS: In the first trimester of pregnancy, 31{\%} of the patients had positive test results for human papillomavirus deoxyribonucleic acid, whereas 35.6{\%} had positive results in the third trimester (P = 1.0). A comparison of first-trimester test results with postpartum results (paired data available from 83 patients) showed a decline from 39.8{\%} positivity to 26.5{\%} (P = .04). Comparing third- trimester results with postpartum results (paired data available from 74 patients) showed a decline from 35.1{\%} to 25.7{\%} positivity (P = .12). When specimens positive for human papillomavirus were divided between those containing 'high cancer risk' types (9 virus types often associated with dysplasia or malignancy) and 'low cancer risk' types (5 types usually found in benign lesions), similar trends were seen, although not all comparisons were statistically significant. CONCLUSION: The increased prevalence, during pregnancy, of detectable human papillomavirus deoxyrlbonucleic acid, which was previously reported (Fife et al, Am J Obstet Gynecol 1996;174:1487-93), persists at a similar level throughout pregnancy but declines in the postpartum period. This observation is most consistent with activation of the virus by the physiologic changes of pregnancy.",
keywords = "Cervical dysplasia, Detection of deoxyribonucleic acid, Papillomavirus, Pregnancy",
author = "Kenneth Fife and Barry Katz and Brizendine, {Edward J.} and Darron Brown",
year = "1999",
doi = "10.1016/S0002-9378(99)70602-2",
language = "English (US)",
volume = "180",
pages = "1110--1114",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period

AU - Fife, Kenneth

AU - Katz, Barry

AU - Brizendine, Edward J.

AU - Brown, Darron

PY - 1999

Y1 - 1999

N2 - OBJECTIVE: Our goal was to determine the persistence of human papillomavirus infection of the cervix in a prospectively evaluated cohort of pregnant women observed from the first trimester until after delivery. STUDY DESIGN: A group of 232 women were enrolled in the first trimester of pregnancy and had cervicovaginal lavage specimens collected for detection of the deoxyribonucleic acid of human papillomavirus. They underwent sampling again in the third trimester (146 patients available) and at 4 to 12 weeks after delivery (83 patients available). Human papillomavirus deoxyribonucleic acid was detected by means of the Hybrid Capture assay. RESULTS: In the first trimester of pregnancy, 31% of the patients had positive test results for human papillomavirus deoxyribonucleic acid, whereas 35.6% had positive results in the third trimester (P = 1.0). A comparison of first-trimester test results with postpartum results (paired data available from 83 patients) showed a decline from 39.8% positivity to 26.5% (P = .04). Comparing third- trimester results with postpartum results (paired data available from 74 patients) showed a decline from 35.1% to 25.7% positivity (P = .12). When specimens positive for human papillomavirus were divided between those containing 'high cancer risk' types (9 virus types often associated with dysplasia or malignancy) and 'low cancer risk' types (5 types usually found in benign lesions), similar trends were seen, although not all comparisons were statistically significant. CONCLUSION: The increased prevalence, during pregnancy, of detectable human papillomavirus deoxyrlbonucleic acid, which was previously reported (Fife et al, Am J Obstet Gynecol 1996;174:1487-93), persists at a similar level throughout pregnancy but declines in the postpartum period. This observation is most consistent with activation of the virus by the physiologic changes of pregnancy.

AB - OBJECTIVE: Our goal was to determine the persistence of human papillomavirus infection of the cervix in a prospectively evaluated cohort of pregnant women observed from the first trimester until after delivery. STUDY DESIGN: A group of 232 women were enrolled in the first trimester of pregnancy and had cervicovaginal lavage specimens collected for detection of the deoxyribonucleic acid of human papillomavirus. They underwent sampling again in the third trimester (146 patients available) and at 4 to 12 weeks after delivery (83 patients available). Human papillomavirus deoxyribonucleic acid was detected by means of the Hybrid Capture assay. RESULTS: In the first trimester of pregnancy, 31% of the patients had positive test results for human papillomavirus deoxyribonucleic acid, whereas 35.6% had positive results in the third trimester (P = 1.0). A comparison of first-trimester test results with postpartum results (paired data available from 83 patients) showed a decline from 39.8% positivity to 26.5% (P = .04). Comparing third- trimester results with postpartum results (paired data available from 74 patients) showed a decline from 35.1% to 25.7% positivity (P = .12). When specimens positive for human papillomavirus were divided between those containing 'high cancer risk' types (9 virus types often associated with dysplasia or malignancy) and 'low cancer risk' types (5 types usually found in benign lesions), similar trends were seen, although not all comparisons were statistically significant. CONCLUSION: The increased prevalence, during pregnancy, of detectable human papillomavirus deoxyrlbonucleic acid, which was previously reported (Fife et al, Am J Obstet Gynecol 1996;174:1487-93), persists at a similar level throughout pregnancy but declines in the postpartum period. This observation is most consistent with activation of the virus by the physiologic changes of pregnancy.

KW - Cervical dysplasia

KW - Detection of deoxyribonucleic acid

KW - Papillomavirus

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0032995920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032995920&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(99)70602-2

DO - 10.1016/S0002-9378(99)70602-2

M3 - Article

C2 - 10329863

AN - SCOPUS:0032995920

VL - 180

SP - 1110

EP - 1114

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -